ProMED-AMR, a partnership between ISID and Public Health England is set to bolster global AMR surveillance

  27 February 2020

The International Society for Infectious Diseases’ (ISID) Program for Monitoring Emerging Diseases (ProMED) is announcing its partnership with Public Health England (PHE), on behalf of the UK’s Department of Health and Social Care, to bolster global antimicrobial resistance (AMR) surveillance through technology transfer, monitoring and evaluation, and information exchange.

The widespread use of antimicrobials, (including their overuse in animals and humans), gaps in infection prevention and control, and inadequate disease surveillance diminishes our arsenal of tools to treat and prevent resistant infections.  The goal of the partnership is to improve situational awareness surrounding AMR and empower astute practitioners with useful data.  This formal collaborative project showcases the strength and reach brought together by two leading public health organizations, focusing on lower- and middle-income countries (LMICs).

Author(s): International Society for Infectious Diseases
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed